查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828202

2025年头颈癌诊断全球市场报告

Head And Neck Cancer Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，头颈癌诊断市场规模迅速扩张，从2024年的17.4亿美元成长到2025年的20.3亿美元，复合年增长率为16.6%。预测期内的成长可归因于烟草和酒精消费的增加、人口老化、意识提升宣传活动、切片检查技术的发展以及医疗基础设施的改善等因素。

预计未来几年头颈癌诊断市场将快速成长，到2029年将达到38.3亿美元，复合年增长率为17.2%。预测期内的增长可归因于基因生物标誌物、HPV相关癌症盛行率的上升、人工智慧(AI)、免疫疗法和标靶治疗的整合，以及医疗保健政策和报销的变化。预测期内的全球趋势包括液态切片的主导地位、多重模式诊断、照护现场诊断、全球合作伙伴关係以及数位病理学的整合。

头颈癌的诊断需要结合多种方法，包括身体检查、影像检查、病历评估和组织切片检查，以识别和确认头颈部的恶性细胞。此诊断程序常用于鳞状细胞癌、喉癌和下嚥癌的治疗。

头颈癌诊断的主要方法包括影像设备、内视镜设备、切片检查筛检和牙科诊断。影像设备包括各种医疗工具，用于产生用于诊断的内臟器官和组织影像。这些诊断过程涉及多个管道，包括零售药局、专科药局、医院药局和线上药局。受益于这些诊断方法的最终用户包括医院、诊断中心等。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供头颈癌诊断市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的头颈癌诊断细分市场、市场趋势和机会，以及您在头颈癌诊断行业取得成功所需的数据。本头颈癌诊断市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为17.2%，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，导致来自法国和荷兰等主要地区的窄频成像内视镜和分子生物标记检测套组的供应链中断，从而导致癌症检测延迟和病理学服务成本上升。此外，这种影响可能会透过互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易造成的负面影响，在更广泛的范围内显现。

预计头颈癌诊断市场的未来成长将受到头颈癌发病率上升的推动。这类肿瘤会影响头部和颈部的各种组织和器官，包括口腔、咽喉、唾液腺、鼻腔和副鼻窦。头颈癌诊断透过切开切片检查和钡餐吞嚥研究等测试在早期发现疾病方面发挥关键作用。例如，2023 年 2 月，美国临床肿瘤学会报告称，头颈癌将占美国所有恶性肿瘤的 4%，预计 2023 年将有 66,920 例病例。包括澳洲在内，全球发病率的上升是头颈癌诊断市场成长的主要驱动力，2022 年将出现 5,189 例新患者。

个人化医疗的日益普及预计将促进头颈癌诊断市场的成长。个人化医疗是指根据每位患者的个别情况制定个人化治疗方案，以优化治疗效果并最大程度地减少副作用。精准影像和个人化追踪护理对于有效管理头颈癌至关重要。 2022年，美国食品药物管理局(FDA) 药品评估与研究中心 (CDER)核准了37个新分子实体 (NME)，其中约34%（相当于12个NME）被个人化医疗联盟 (PMC) 归类为个人化医疗。个人化医疗的普及反映了推动头颈癌诊断市场成长的关键趋势。

产品创新是头颈癌诊断市场的突出趋势，领先公司专注于开发创新产品以巩固其市场地位。例如，2023 年 5 月，印度医疗保健公司 Alkem Laboratories Ltd. 推出了全球首个用于治疗头颈癌的生物相似药 Cetuxa。 Cetuxa 是西妥昔单抗的生物相似药，西Cetuximab昔单抗是一种具有抗肿瘤特性的单株抗体，可抑制受体依赖性讯号路径。它与表皮生长因子受体 (EGFR) 的胞外结构域结合。在临床实践中，Cetuximab通常与化疗和/或放射线治疗结合，用于治疗局部进行性、復发性和转移性头颈部鳞状细胞癌。

头颈癌诊断市场由提供牙科全景X光片、磁振造影(MRI) 和电脑断层扫描 (CT) 扫描的营业单位所获得的收益所构成。市场规模还包括服务提供者销售或包含在其服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球头颈癌诊断：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球头颈癌诊断市场：成长率分析
  • 全球头颈癌诊断市场表现：规模与成长，2019-2024
  • 全球头颈癌诊断市场预测：规模与成长，2024-2029，2034
  • 全球头颈癌诊断：总目标市场（TAM）

第六章 市场细分

  • 全球头颈癌诊断市场（依诊断方法、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 诊断影像设备
  • 内视镜设备
  • 切片检查筛检测试
  • 牙科诊断
  • 其他的
  • 全球头颈癌诊断市场（按通路、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 零售和专业药局
  • 医院药房
  • 网路药局
  • 全球头颈癌诊断市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 其他的
  • 全球头颈癌诊断市场：诊断影像设备细分、类型、效能及预测（2019-2024、2024-2029、2034）
  • 电脑断层扫描（CT）
  • 磁振造影（MRI）
  • 正子断层扫描（PET）
  • X射线
  • 全球头颈癌诊断市场：内视镜设备细分，按类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 硬内视镜
  • 柔性内视镜
  • 影像内视镜系统
  • 全球头颈癌诊断市场：切片检查筛检测试细分、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 细针抽吸切片检查（FNA）
  • 芯针切片
  • 手术切片检查
  • 全球头颈癌诊断市场：牙科诊断细分市场、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 口内摄影机
  • 牙科X光相片
  • 口腔癌筛检仪
  • 全球头颈癌诊断市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 分子诊断
  • 血液检查
  • 基因检测

第七章 区域和国家分析

  • 全球头颈癌诊断市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球头颈癌诊断市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 头颈癌诊断市场：竞争格局
  • 头颈癌诊断市场：公司简介
    • F. Hoffmann-La Roche Ltd.
    • Bristol Myers Squibb Co.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • BioNTech AG

第31章：其他领先和创新企业

  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Laboratory Corporation of America
  • Agilent Technologies Inc.
  • Hologic Inc.
  • Illumina Inc.
  • Shimadzu Corporation
  • Sysmex Corp.
  • Varian Medical Systems Inc.
  • QIAGEN NV
  • Exact Sciences Corp.
  • Bio-Techne Corp.
  • Carestream Health Inc.
  • Myriad Genetics Inc.
  • Cepheid Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年头颈癌诊断市场：提供新机会的国家
  • 2029年头颈癌诊断市场：细分市场带来新机会
  • 2029年头颈癌诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24988u

Head and neck cancer diagnostics involve the identification and confirmation of malignant cells in the head and neck region through a combination of methods, including physical examination, imaging tests, medical history assessment, and tissue biopsy. This diagnostic process is commonly applied in the treatment of squamous cell carcinomas, laryngeal cancer, and hypopharyngeal cancer.

The primary methods employed in head and neck cancer diagnostics include diagnostic imaging equipment, endoscopy screening equipment, biopsy screening tests, dental diagnostic methods, and others. Diagnostic imaging equipment comprises various medical tools utilized to generate images of the internal organs and tissues for diagnostic purposes. These diagnostic processes involve multiple channels, including retail and specialty pharmacies, hospital pharmacies, and online pharmacies. The end-users benefiting from these diagnostic methods encompass hospitals, diagnostic centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The head and neck cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides head and neck cancer diagnostics market statistics, including head and neck cancer diagnostics industry global market size, regional shares, competitors with a head and neck cancer diagnostics market share, detailed head and neck cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the head and neck cancer diagnostics industry. This head and neck cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The head and neck cancer diagnostics market size has grown rapidly in recent years. It will grow from $1.74 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to tobacco and alcohol consumption, increasing aging population, awareness campaigns, biopsy techniques development, healthcare infrastructure development.

The head and neck cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $3.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to genomic biomarkers, rising incidence of hpv-related cancers, integration of artificial intelligence (ai), immunotherapy and targeted therapies, healthcare policy and reimbursement changes. Major trends in the forecast period include liquid biopsy dominance, multi-modality diagnostics, point-of-care diagnostics, global collaborations and partnerships, digital pathology integration.

The forecast of 17.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for narrow-band imaging endoscopes and molecular biomarker test kits, sourced from key regions such as France and the Netherlands, which could lead to delayed cancer detection and increased pathology service costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth in the head and neck cancer diagnostics market in the future is expected to be driven by the increasing incidence of head and neck cancer. This group of tumors affects various tissues and organs in the head and neck region, including the mouth, pharynx, larynx, salivary glands, nasal cavity, and sinuses. Head and neck cancer diagnostics play a crucial role in the early detection of the disease through tests such as incisional biopsy and barium swallow test. For example, in February 2023, the American Society of Clinical Oncology reported that head and neck cancer constituted 4% of all malignancies in the United States, with an estimated 66,920 people expected to be affected by it in 2023. This rise in incidence globally, such as in Australia, where there were 5,189 new cases in 2022, is a key driver for the growth of the head and neck cancer diagnostics market.

The increasing adoption of personalized medicines is expected to contribute to the growth of the head and neck cancer diagnostics market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, optimizing treatment outcomes, and minimizing side effects. Precision imaging and individualized follow-up care are crucial in managing head and neck cancers effectively. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), and approximately 34% of these, equivalent to 12 NMEs, were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This adoption of personalized medicine reflects a significant trend driving the growth of the head and neck cancer diagnostics market.

Product innovation is a prominent trend gaining traction in the head and neck cancer diagnostic market, with major players focusing on developing innovative products to strengthen their market position. For example, in May 2023, Alkem Laboratories Ltd., an India-based healthcare company, introduced Cetuxa, the world's first biosimilar for treating head and neck cancer. Cetuxa is a biosimilar to cetuximab, a monoclonal antibody with anti-tumor properties that inhibits the receptor-dependent transduction pathway. It binds to the extracellular domain of the epidermal growth factor receptor (EGFR). Clinical practice often combines cetuximab with chemotherapy or radiation therapy for treating locally advanced, recurring, or metastatic squamous cell carcinoma of the head and neck.

Major companies in the head and neck cancer diagnostics market are actively developing new products, such as antibodies, to gain a competitive advantage. Antibodies are proteins produced by the immune system in response to foreign substances. For instance, in February 2023, Roche Holding AG, a Switzerland-based pharmaceutical company, launched IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and ATRX Rabbit Polyclonal Antibody, offering advanced features in brain cancer diagnostics. These antibodies are specifically designed to detect mutations in the IDH1 and ATRX genes, providing clinicians with crucial diagnostic and prognostic information. The IDH1 antibody identifies the IDH1 R132H mutation in adult-type gliomas and acute myeloid leukemia (AML), aiding patient stratification for clinical trials. The ATRX antibody detects mutations in the ATRX gene, offering valuable insights for clinicians managing IDH-mutant gliomas.

In May 2022, Regeneron Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Checkmate Pharmaceuticals Inc. for an undisclosed amount. This acquisition is expected to enhance Regeneron Pharmaceuticals' position as a leader in immuno-oncology and expand its strategic adaptability and innovation with promising monotherapy and combination candidates for challenging malignancies. Checkmate Pharmaceuticals Inc., a US-based biopharmaceutical company, focuses on discovering and developing cancer immunotherapy approaches, including immuno-oncology treatments for head and neck cancer.

Major companies operating in the head and neck cancer diagnostics market include F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Co., Abbott Laboratories, Siemens Healthineers AG, BioNTech AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Laboratory Corporation of America, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Shimadzu Corporation, Sysmex Corp., Varian Medical Systems Inc., QIAGEN N.V., Exact Sciences Corp., Bio-Techne Corp., Carestream Health Inc., Myriad Genetics Inc., Cepheid Inc., Invitae Corporation, Accuray Inc., Canon Medical Systems Corporation, NanoString Technologies Inc, Asuragen Inc., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc., Oncgnostics GmbH, Perseus Proteomics Inc., VolitionRx Ltd.

North America was the largest region in the head and neck cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the head and neck cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The head and neck cancer diagnostic market consists of revenues earned by entities by providing panoramic dental X-ray, magnetic resonance imaging (MRI), and computerized tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Head And Neck Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on head and neck cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for head and neck cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The head and neck cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Method: Diagnostic Imaging Equipment; Endoscopy Screening Equipment; Biopsy Screening Tests; Dental Diagnostic Methods; Other Diagnostic Methods
  • 2) By Channel: Retail And Specialty Pharmacies; Hospital Pharmacies; Online Pharmacies
  • 3) By End-User: Hospitals; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Diagnostic Imaging Equipment: Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans; X-rays
  • 2) By Endoscopy Screening Equipment: Rigid Endoscopes; Flexible Endoscopes; Video Endoscopy Systems
  • 3) By Biopsy Screening Tests: Fine Needle Aspiration (FNA) Biopsy; Core Needle Biopsy; Surgical Biopsy
  • 4) By Dental Diagnostic Methods: Intraoral Cameras; Dental X-rays; Oral Cancer Screening Devices
  • 5) By Other Diagnostic Methods: Molecular Diagnostics; Blood Tests; Genetic Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Bristol Myers Squibb Co.; Abbott Laboratories; Siemens Healthineers AG; BioNTech AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Laboratory Corporation of America; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.; Shimadzu Corporation; Sysmex Corp.; Varian Medical Systems Inc.; QIAGEN N.V.; Exact Sciences Corp.; Bio-Techne Corp.; Carestream Health Inc.; Myriad Genetics Inc.; Cepheid Inc.; Invitae Corporation; Accuray Inc.; Canon Medical Systems Corporation; NanoString Technologies Inc; Asuragen Inc.; Caris Life Sciences Inc.; HTG Molecular Diagnostics Inc.; Oncgnostics GmbH; Perseus Proteomics Inc.; VolitionRx Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Head And Neck Cancer Diagnostics Market Characteristics

3. Head And Neck Cancer Diagnostics Market Trends And Strategies

4. Head And Neck Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Head And Neck Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Head And Neck Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Head And Neck Cancer Diagnostics Market Growth Rate Analysis
  • 5.4. Global Head And Neck Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Head And Neck Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Head And Neck Cancer Diagnostics Total Addressable Market (TAM)

6. Head And Neck Cancer Diagnostics Market Segmentation

  • 6.1. Global Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Imaging Equipment
  • Endoscopy Screening Equipment
  • Biopsy Screening Tests
  • Dental Diagnostic Methods
  • Other Diagnostic Methods
  • 6.2. Global Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retail And Specialty Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • 6.3. Global Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Other End Users
  • 6.4. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Diagnostic Imaging Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Computed Tomography (CT) Scans
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET) Scans
  • X-rays
  • 6.5. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Endoscopy Screening Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rigid Endoscopes
  • Flexible Endoscopes
  • Video Endoscopy Systems
  • 6.6. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Biopsy Screening Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fine Needle Aspiration (FNA) Biopsy
  • Core Needle Biopsy
  • Surgical Biopsy
  • 6.7. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Dental Diagnostic Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intraoral Cameras
  • Dental X-rays
  • Oral Cancer Screening Devices
  • 6.8. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Other Diagnostic Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Blood Tests
  • Genetic Testing

7. Head And Neck Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global Head And Neck Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Head And Neck Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Head And Neck Cancer Diagnostics Market

  • 8.1. Asia-Pacific Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Head And Neck Cancer Diagnostics Market

  • 9.1. China Head And Neck Cancer Diagnostics Market Overview
  • 9.2. China Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Head And Neck Cancer Diagnostics Market

  • 10.1. India Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Head And Neck Cancer Diagnostics Market

  • 11.1. Japan Head And Neck Cancer Diagnostics Market Overview
  • 11.2. Japan Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Head And Neck Cancer Diagnostics Market

  • 12.1. Australia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Head And Neck Cancer Diagnostics Market

  • 13.1. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Head And Neck Cancer Diagnostics Market

  • 14.1. South Korea Head And Neck Cancer Diagnostics Market Overview
  • 14.2. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Head And Neck Cancer Diagnostics Market

  • 15.1. Western Europe Head And Neck Cancer Diagnostics Market Overview
  • 15.2. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Head And Neck Cancer Diagnostics Market

  • 16.1. UK Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Head And Neck Cancer Diagnostics Market

  • 17.1. Germany Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Head And Neck Cancer Diagnostics Market

  • 18.1. France Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Head And Neck Cancer Diagnostics Market

  • 19.1. Italy Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Head And Neck Cancer Diagnostics Market

  • 20.1. Spain Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Head And Neck Cancer Diagnostics Market

  • 21.1. Eastern Europe Head And Neck Cancer Diagnostics Market Overview
  • 21.2. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Head And Neck Cancer Diagnostics Market

  • 22.1. Russia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Head And Neck Cancer Diagnostics Market

  • 23.1. North America Head And Neck Cancer Diagnostics Market Overview
  • 23.2. North America Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Head And Neck Cancer Diagnostics Market

  • 24.1. USA Head And Neck Cancer Diagnostics Market Overview
  • 24.2. USA Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Head And Neck Cancer Diagnostics Market

  • 25.1. Canada Head And Neck Cancer Diagnostics Market Overview
  • 25.2. Canada Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Head And Neck Cancer Diagnostics Market

  • 26.1. South America Head And Neck Cancer Diagnostics Market Overview
  • 26.2. South America Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Head And Neck Cancer Diagnostics Market

  • 27.1. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Head And Neck Cancer Diagnostics Market

  • 28.1. Middle East Head And Neck Cancer Diagnostics Market Overview
  • 28.2. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Head And Neck Cancer Diagnostics Market

  • 29.1. Africa Head And Neck Cancer Diagnostics Market Overview
  • 29.2. Africa Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Head And Neck Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Head And Neck Cancer Diagnostics Market Competitive Landscape
  • 30.2. Head And Neck Cancer Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bristol Myers Squibb Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. BioNTech AG Overview, Products and Services, Strategy and Financial Analysis

31. Head And Neck Cancer Diagnostics Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips N.V.
  • 31.2. GE HealthCare Technologies Inc.
  • 31.3. Laboratory Corporation of America
  • 31.4. Agilent Technologies Inc.
  • 31.5. Hologic Inc.
  • 31.6. Illumina Inc.
  • 31.7. Shimadzu Corporation
  • 31.8. Sysmex Corp.
  • 31.9. Varian Medical Systems Inc.
  • 31.10. QIAGEN N.V.
  • 31.11. Exact Sciences Corp.
  • 31.12. Bio-Techne Corp.
  • 31.13. Carestream Health Inc.
  • 31.14. Myriad Genetics Inc.
  • 31.15. Cepheid Inc.

32. Global Head And Neck Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Head And Neck Cancer Diagnostics Market

34. Recent Developments In The Head And Neck Cancer Diagnostics Market

35. Head And Neck Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Head And Neck Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Head And Neck Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Head And Neck Cancer Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer